Impact of Semaglutide Withdrawal on Cardiometabolic Profile and Physiology of Energy Balance: Recovery Effects After Semaglutide Termination

Abroad (travel likely)RecruitingPHASE3

Conditions

Obesity (Disorder) · Weight Change · Blood Pressure Monitoring · Appetite Regulation

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Leadership Sinai Centre for Diabetes, Toronto, Ontario, Canada
Contact: Study coordinator (Caroline K Kramer, MD PhD) · caroline.kramer@sinaihealth.ca · +14165864800 ext 7628

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Examination of How the Duration of Fasting and Temporary Stopping of GLP-1 Medications Affect the Amount of Food Left in the Stomach in People Using Liraglutide (Injected), Semaglutide (Taken by Mouth) or Semaglutide (Injected)

Obesity

Abroad (travel likely)RecruitingPHASE1

Cypress, United States

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

Atherosclerotic Cardiovascular Disease · Overweight · Obesity

Abroad (travel likely)RecruitingPHASE3

Daphne, United States · Fairhope, United States

AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

Obesity · Overweight · Obstructive Sleep Apnoea

Abroad (travel likely)RecruitingPHASE3

Gilbert, United States · Bradenton, United States

A Study of XW003 in Obese Participants With Obstructive Sleep Apnea But Not Receive Positive Airway Pressure Therapy

OSA - Obstructive Sleep Apnea · Obesity

Abroad (travel likely)RecruitingPHASE3

Beijing, China